Welcome to our dedicated page for Microchip Technology SEC filings (Ticker: MCHP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Microchip Technology Inc. filings document operating results, material events, governance matters, and capital-structure disclosures for a public semiconductor company. Form 8-K reports include quarterly and annual results, financial-condition exhibits, material-event disclosures, material agreements, and securities information for common stock and depositary shares representing interests in 7.50% Series A Mandatory Convertible Preferred Stock.
Proxy and annual meeting filings cover board elections, auditor ratification, executive compensation, shareholder voting matters, and related governance disclosures. The company’s regulatory record also provides formal disclosure on security listings, stockholder approvals, and the corporate actions and risk topics associated with its semiconductor product portfolio and public-company obligations.
Sanghi Steve reported acquisition or exercise transactions in this Form 4 filing.
Microchip Technology Inc. reported that President, CEO and Chair of the Board Steve Sanghi received a grant of 3,446 restricted stock units. Each unit represents a contingent right to receive one share of Microchip common stock. The units will vest in full on May 15, 2028, provided he remains a service provider through that date, and vested shares will be delivered upon vesting.
Following this award, Sanghi holds 3,446 restricted stock units directly and 9,385,834 shares of common stock indirectly, with 3,479,962 shares held by The Sanghi Trust and 5,905,872 shares held by The Sanghi Family Limited Partnership.
Krawczyk Joseph R II reported acquisition or exercise transactions in this Form 4 filing.
Microchip Technology Inc. senior vice president Joseph R. Krawczyk II reported a compensation-related award of 212 restricted stock units, each representing a contingent right to receive one share of common stock. These units will vest in full on May 15, 2027, provided he remains a service provider through that date.
Upon vesting, the corresponding shares of common stock will be delivered to him. The filing also shows he directly holds 13,926 shares of Microchip common stock after the reported transactions, indicating this grant is modest compared with his existing equity position.
Bunker Mathew B reported acquisition or exercise transactions in this Form 4 filing.
Microchip Technology Inc. senior vice president of operations Mathew B. Bunker received a grant of 203 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Microchip common stock. The RSUs will vest in full on May 15, 2027, provided he remains a service provider through that date, and vested shares will be delivered upon vesting.
After this filing, Bunker is shown holding 25,158 shares of Microchip common stock directly, along with the 203 newly granted RSUs.
Bjornholt James Eric reported acquisition or exercise transactions in this Form 4 filing.
Microchip Technology Senior VP and CFO James Eric Bjornholt reported a compensation-related equity grant and his indirect holdings. He received 279 restricted stock units, each representing a contingent right to one share of Microchip common stock. These units will vest in full on May 15, 2027, provided he continues as a service provider through that date, and the vested shares will be delivered upon vesting.
The filing also shows 28,573 shares of common stock held indirectly through a trust. No open-market purchases or sales were reported, making this a routine update to disclose equity awards and existing indirect ownership.
Microchip Technology reported strong results for the quarter ended March 31, 2026, with net sales of $1.311 billion, up 35.1% year over year and above its prior guidance midpoint of $1.260 billion. GAAP diluted EPS was $0.21, while non-GAAP diluted EPS reached $0.57, topping the earlier non-GAAP guidance range of $0.48 to $0.52.
Non-GAAP operating income for the quarter was $400.9 million, or 30.6% of net sales, compared to 14.0% a year earlier, showing substantial margin expansion. For fiscal 2026, net sales were $4.713 billion, up 7.1%, with non-GAAP net income of $933.9 million and non-GAAP EPS of $1.64, both rising more than 25% versus the prior year.
Management guided first-quarter fiscal 2027 net sales to $1.442–$1.469 billion, implying 35.3% year-over-year and 11% sequential growth at the midpoint, and expects non-GAAP EPS of $0.67–$0.71. The company highlighted improving demand, inventory reductions, growing data center and AI design activity, and strong free cash flow of $242.8 million in the quarter. It also declared a quarterly common dividend of $0.455 per share and a preferred dividend of $18.750 per Series A share.
Microchip Technology reported strong results for the quarter ended March 31, 2026, with net sales of $1.311 billion, up 35.1% year over year and above its prior guidance midpoint of $1.260 billion. GAAP diluted EPS was $0.21, while non-GAAP diluted EPS reached $0.57, topping the earlier non-GAAP guidance range of $0.48 to $0.52.
Non-GAAP operating income for the quarter was $400.9 million, or 30.6% of net sales, compared to 14.0% a year earlier, showing substantial margin expansion. For fiscal 2026, net sales were $4.713 billion, up 7.1%, with non-GAAP net income of $933.9 million and non-GAAP EPS of $1.64, both rising more than 25% versus the prior year.
Management guided first-quarter fiscal 2027 net sales to $1.442–$1.469 billion, implying 35.3% year-over-year and 11% sequential growth at the midpoint, and expects non-GAAP EPS of $0.67–$0.71. The company highlighted improving demand, inventory reductions, growing data center and AI design activity, and strong free cash flow of $242.8 million in the quarter. It also declared a quarterly common dividend of $0.455 per share and a preferred dividend of $18.750 per Series A share.
Microchip Technology reported strong results for the quarter ended March 31, 2026, with net sales of $1.311 billion, up 35.1% year over year and above its prior guidance midpoint of $1.260 billion. GAAP diluted EPS was $0.21, while non-GAAP diluted EPS reached $0.57, topping the earlier non-GAAP guidance range of $0.48 to $0.52.
Non-GAAP operating income for the quarter was $400.9 million, or 30.6% of net sales, compared to 14.0% a year earlier, showing substantial margin expansion. For fiscal 2026, net sales were $4.713 billion, up 7.1%, with non-GAAP net income of $933.9 million and non-GAAP EPS of $1.64, both rising more than 25% versus the prior year.
Management guided first-quarter fiscal 2027 net sales to $1.442–$1.469 billion, implying 35.3% year-over-year and 11% sequential growth at the midpoint, and expects non-GAAP EPS of $0.67–$0.71. The company highlighted improving demand, inventory reductions, growing data center and AI design activity, and strong free cash flow of $242.8 million in the quarter. It also declared a quarterly common dividend of $0.455 per share and a preferred dividend of $18.750 per Series A share.
Microchip Technology (MCHP) director, president, CEO and chair Steve Sanghi reported two indirect open‑market sales of common stock by entities associated with him under a Rule 10b5‑1 trading plan. On April 30, 2026, 33,502 shares were sold at an average price of $92.3729 per share. On May 1, 2026, 76,469 shares were sold at an average price of $93.5843 per share, for total reported sales of 109,971 shares. After these transactions, 9,385,834 shares of Microchip Technology common stock are reported as indirectly held, including shares held by The Sanghi Trust and The Sanghi Family Limited Partnership.
Microchip Technology reported insider sale activity by Steve Sanghi via Form 144. The filing lists three sales in the past three months: 94,869 shares on 02/12/2026 for $7,823,191.83, 416,581 shares on 04/23/2026 for $36,880,749.10, and 33,502 shares on 04/30/2026 for $3,094,676.90. The filing also shows prior option exercises (37,920; 25,000) and an RSU vesting (13,549).
Microchip Technology (MCHP) notice of proposed sale: the filing lists proposed sales of Common Stock under Rule 144 and discloses prior sales during the past three months by Steve Sanghi. The excerpt shows prior disposals of 94,869 shares on 02/12/2026 and 416,581 shares on 04/23/2026 with reported aggregate values of $7,823,191.83 and $36,880,749.10, respectively.
The filing also references a block of 33,502 shares tied to an option exercise (11/14/2012) and lists Fidelity Brokerage Services LLC as a broker address. The notice is a routine regulatory disclosure of proposed resale activity under Rule 144.
Vanguard Capital Management files a Schedule 13G reporting beneficial ownership of 7.50% of Microchip Technology Inc common stock. The filing states Vanguard Capital Management beneficially owns 40,620,884 shares and reports sole dispositive power over 40,620,884 shares and sole voting power for 5,495,811 shares as of 03/31/2026. The filing notes ownership includes securities held for Vanguard funds and managed accounts under the reporting business unit. The filing is signed by Vanguard's Head of Global Fund Administration on 04/30/2026.
Vanguard Portfolio Management reported beneficial ownership of 32,469,341 shares of Microchip Technology Inc. common stock, representing 6% of the class as of 03/31/2026. The filing shows sole voting power for 63,962 shares and sole dispositive power for 32,469,341 shares. The report is signed by Ashley Grim on 04/29/2026.